CD8A and neoplasm: To confirm that the migration of CD8+ T-cells into the tumour is indeed important for the IAV-mediated antitumor response, we treated non-infected and infected tumour-bearing mice with FTY720, which is an inhibitor of lymphocyte emigration from lymphoid organs.